Male medical worker pipetting chemical in test tube while working in laboratory

Defining the path to TBK1 inhibition with QSAR modeling

TANK-binding kinase 1 (TBK1) plays a key role in various cellular processes and, consequentially, in the pathophysiology of many diseases, from autoimmune diseases to viral infections. While TBK1 has seen increasing amounts of research in the past two decades, there are currently no available FDA-approved TBK1 inhibitors on the market due to safety, efficacy, and resource concerns.  

In this CAS InsightsTM report, we study the landscape of TBK1 through the lens of the CAS Content CollectionTM and investigate whether QSAR computer modeling – using chemical structures, the experimental activity of existing chemicals, and mathematical tools to predict the activity of new chemicals — can accelerate the development of effective TBK1 inhibitors.

TBK1 Fanned image

Download the insights report

Related CAS Insights

Digital R&D

AI for science: Six trends powering cutting-edge research

May 28, 2025

Read article
Digital R&D

AI in Pharma: Data strategies fuel successful drug repurposing

November 7, 2024

Read article
Digital R&D

AI’s emerging role in natural product drug discovery

January 18, 2024

Read article

Gain new perspectives for faster progress directly to your inbox.